Clinical Trials Logo
  1. Home
  2. Port Wine Stain
  3. NCT00585247

Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks — Aldara  

Port Wine Stain Clinical Trial

Official title:
Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks

Clinical Trial Summary

Port wine stains are red birthmarks that without treatment persist for a lifetime. They are frequently found on the face and can be conspicuous and disfiguring, negatively impacting social interactions for these patients. Treating Port wine stains is difficult. The standard of care is to use laser treatment, but over 80% of patients fail to completely clear despite multiple treatments. The growth of additional blood vessels (angiogenesis) following the Laser treatment is likely an important factor in why these lesions persist despite therapy.

Clinical Trial Description

Imiquimod is a topical cream that affects the immune response and has been noted to inhibit blood vessel formation. It has been used to successfully treat other vascular growths such as hemangiomas. The research can use imiquimod cream 5% cream apply to port wine stains after laser therapy to improve lightening of port wine stains. The imiquimod 5% cream cream apply to Port wine stains everyday for 8 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00585247
Study type Interventional
Source University of California, Irvine
Contact
Status Completed
Phase N/A
Start date November 2006
Completion date August 2012
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT01438047 - Optical Frequency Domain Imaging (OFDI) in Dermatology N/A
Terminated NCT00782483 - Personalized Interactive Laser Therapy of Port Wine Stain N/A
Completed NCT03948997 - The Role of Angiogenesis-related Pathways in the Development of Port Wine Stains N/A
Completed NCT01364857 - French National Cohort of Children With Port Wine Stain N/A
Withdrawn NCT00969397 - Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks Phase 1/Phase 2
Completed NCT00800722 - A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks. Phase 1
Active, not recruiting NCT00247299 - Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform N/A
Completed NCT00580736 - Optical Clearing of the Skin in Conjunction With Laser Treatments Phase 1
Completed NCT00540566 - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Withdrawn NCT02035319 - Effect of Laser Treatment on Capillary Malformations N/A
Withdrawn NCT01166919 - Pilot Study on the Use of the Matrix Radiofrequencyfor Treatment of Port Wine Stain Birthmarks Phase 1
Completed NCT00830466 - A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks. Phase 1
Completed NCT00540371 - Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
Completed NCT01333553 - Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
Withdrawn NCT00580944 - Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks Phase 1